Moderna, Pfizer and now Johnson & Johnson will deliver enough doses to fully vaccinate 130 million people -- more than one-third of the US population -- by the end of March, the pharmaceutical companies told a House subcommittee last week.

COVID-19 Vaccine Q&A

Latest Video Updates

COVID-19 In Georgia